Rheumatology International

Papers
(The TQCC of Rheumatology International is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review308
Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management214
SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis116
Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey92
ANCA-associated vasculitis after COVID-1987
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment84
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study79
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic78
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes75
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly73
YouTube as a source of information on gout: a quality analysis69
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews69
The Beighton Score as a measure of generalised joint hypermobility67
COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey67
Kawasaki-like disease in children with COVID-1965
The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey64
Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review63
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey58
Comorbidities in psoriatic arthritis: a systematic review and meta-analysis56
Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands55
Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic53
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis52
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry52
COVID-19 pandemic in Japan47
Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent47
Reactive arthritis after COVID-19: a case-based review45
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review44
Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic42
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis41
The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk39
Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural–urban gap and north–south gradient38
Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study38
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol37
Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic34
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates33
Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes32
Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-1932
Immune checkpoint inhibitor-induced musculoskeletal manifestations32
Implications of COVID-19 in pediatric rheumatology32
Sex hormones, autoimmunity and gender disparity in COVID-1931
Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting31
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development30
The prevalence of fibromyalgia in axial spondyloarthritis29
Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)28
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study28
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination27
Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound26
The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis25
Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-1925
Rheumatologists’ practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt25
Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends25
Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging24
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review24
Corticosteroid monotherapy for the management of Takayasu arteritis—a systematic review and meta-analysis23
Statistical data presentation: a primer for rheumatology researchers23
Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease22
Are patients with hypermobile Ehlers–Danlos syndrome or hypermobility spectrum disorder so different?22
Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions21
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review21
Prevalence of osteoarthritis in lower middle- and low-income countries: a systematic review and meta-analysis21
Measurement of sedentary time and physical activity in rheumatoid arthritis: an ActiGraph and activPAL™ validation study20
Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities20
Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection20
Post-publication promotion in rheumatology: a survey focusing on social media19
Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database19
The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis19
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–201719
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients19
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt19
Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists19
Publication activity in the field of Sjögren’s syndrome: a ten-year Web of Science based analysis19
Granulomatous mastitis, erythema nodosum and arthritis syndrome: case-based review18
Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review18
Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases18
Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review18
Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America17
Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of da17
The effectiveness and safety of electrotherapy in the management of fibromyalgia17
Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study17
YouTube videos as a source of information concerning Behçet’s disease: a reliability and quality analysis17
A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient17
Treatment of refractory adult onset Still’s disease with tocilizumab—a single centre experience and literature review17
Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective “real world” data analysis of fibromyalgia patients17
Ankylosing spondylitis rehabilitation publications and the global productivity: a Web of Science-based bibliometric analysis (2000–2019)16
The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study16
YouTube as a source of information on COVID-19 vaccination in rheumatic diseases16
Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry16
The relationship between cervical proprioception and balance in patients with fibromyalgia syndrome15
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort15
Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine15
Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study15
The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C)15
Contribution of Arab Countries to Familial Mediterranean Fever Research: a PubMed-based bibliometric analysis15
Why do some people with severe chronic pain adhere to walking prescriptions whilst others won’t? A cross-sectional study exploring clinical and psychosocial predictors in women with fibromyalgia15
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data15
The influence of perioperative interventions targeting psychological distress on clinical outcome after total knee arthroplasty14
‘But you don’t look sick’: a qualitative analysis of the LUPUS UK online forum14
Targeted high concentration botulinum toxin A injections in patients with Raynaud’s phenomenon: a retrospective single-centre experience14
Epidemiology and genetics of granulomatosis with polyangiitis14
Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet’s disease, and iBCG-induced ReA14
Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population14
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry14
Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study14
Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study14
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed14
Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort13
Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents13
Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry13
Patient self-sampling: a cornerstone of future rheumatology care?13
Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis13
Self-limiting COVID‐19-associated Kikuchi‐Fujimoto disease with heart involvement: case-based review13
The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT13
#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic13
Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective13
0.052813053131104